Bioactive Lipid Mediators in Cardiopulmonary Pharmacology

<p>Preface</p> <p>Darryl C. Zeldin and John Seubert</p> <p>1. Bioactive lipids in hypertension</p> <p>John D. Imig</p> <p>2. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response</p> <p>Mohammed A. Nayeem, Werner J. Geldenhuys and Ahmad Hanif</p> <p>3. Cyclooxygenases, eicosanoids and platelets</p> <p>Annalisa Bruno, Stefania Tacconelli, Annalisa Contursi, Patrizia Ballerini and Paola Patrignani</p> <p>4. The roles of eicosanoids in myocardial diseases</p> <p>Zuowen He and Dao Wen Wang</p> <p>5. Cardioprotective mechanisms of cytochrome P450 derived oxylipins from ⍵-3 and ⍵-6 PUFAs</p> <p>Christi Cho, Theresa Aliwarga, Alexandra M. Wiley and Rheem A. Totah</p> <p>6. 20-Hydroxyeicosatetraenoic acid (20-HETE): Bioactions, receptors, vascular function, cardiometabolic disease and beyond</p> <p>Jonathan V. Pascale, Alexandra Wolf, Yonaton Kadish, Danielle Diegisser, Melissa-Maria Kulaprathazhe, Danait Yemane, Samir Ali, Namhee Kim, David E. Baruch, Muhamad Afiq Faisal Bin Yahaya, Ercument Dirice, Adeniyi M. Adebesin, John R. Falck, Michal L. Schwartzman and Victor Garcia</p> <p>7. Insights into the role of the resolvin D2-GPR18 signaling axis in cardiovascular physiology and disease</p> <p>Matthew Spite and Gabrielle Fredman</p> <p>8. Cytochrome P450-derived eicosanoids in brain: From basic discovery to clinical translation</p> <p>Catherine M. Davis, Aseel H. Ibrahim and Nabil J. Alkayed</p> <p>9. Lipid mediators generated by the cytochrome P450: Epoxide hydrolase pathway</p> <p>Timo Frömel, Jiong Hu and Ingrid Fleming</p> <p>10. Role of omega-3 and omega-6 endocannabinoids in cardiopulmonary pharmacology</p> <p>Tiffany Y.-C. Tang, Justin S. Kim and Aditi Das</p> <p>11. Oxylipins in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD)</p> <p>Kimberley Cousins, Chien-Chang Chen, Esha Sehanobish and Elina Jerschow</p>